Literature DB >> 11452143

Effect of TCDD exposure on CYP1A1 and CYP1B1 expression in explant cultures of human endometrium.

D P Bofinger1, L Feng, L H Chi, J Love, F D Stephen, T R Sutter, K G Osteen, T G Costich, R E Batt, S T Koury, J R Olson.   

Abstract

Endometriosis is a debilitating disease estimated to affect 10% of reproductive-age women and characterized by the growth of endometrial tissue outside of the uterus. The present study characterizes a human endometrial explant culture model for studying the direct effects of TCDD exposure by assessing the expression of CYP1A1 and CYP1B1 mRNA (Northern blotting), protein (Western blotting), and activity (7-ethoxyresorufin-O-deethylase; EROD) in explants cultured with and without TCDD. Explants were obtained at laparoscopy or laparotomy from women undergoing surgery for tubal ligation, endometriosis, or pelvic pain unrelated to endometriosis. The explants were cultured with 10 nM estradiol (E(2)) or 1 nM E(2) plus 500 nM progesterone (P(4)) with or without TCDD (first 24 h). The expression of CYP1A1 and CYP1B1 mRNA was greatest with 10 nM TCDD and increased up to 72 h after initial exposure. EROD activity increased up to 120 h. Explants from a secretory phase biopsy became reorganized in culture and formed a new epithelial membrane, while maintaining basic endometrial morphology and viability for up to 120 h. At 24 h, TCDD significantly increased CYP1A1 and CYP1B1 mRNA, and at 72 h, TCDD significantly increased EROD activity and CYP1B1 protein compared to explants cultured without TCDD for similar times. CYP1B1 protein also exhibited substantial constitutive expression that was similar in uncultured biopsies, where CYP1B1 protein was immunolocalized in the cytoplasm of epithelial glands, with only occasional patches of protein in the surface epithelial membrane. In explants cultured with and without TCDD exposure, CYP1B1 protein was localized in the cytoplasm of the new surface epithelial membrane and glands closest to the surface. CYP1A1 protein was not detected in uncultured biopsies or explants. Both younger age (age 30 and under) and proliferative phase were associated with higher TCDD-induced EROD activity in specimens treated with E(2):P(4). No significant endometriosis-related differences were observed for any of the biomarkers, but the detection of disease-specific change was limited by small sample size and variability in tissue-cycle phase. The human endometrial explant culture model will be useful for future studies of the effects of dioxin-like compounds on human endometrium in relationship to cycle phase and hormonal exposure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11452143     DOI: 10.1093/toxsci/62.2.299

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  15 in total

1.  Methoxychlor reduces estradiol levels by altering steroidogenesis and metabolism in mouse antral follicles in vitro.

Authors:  Mallikarjuna S Basavarajappa; Zelieann R Craig; Isabel Hernández-Ochoa; Tessie Paulose; Traci C Leslie; Jodi A Flaws
Journal:  Toxicol Appl Pharmacol       Date:  2011-04-14       Impact factor: 4.219

Review 2.  Dioxin may promote inflammation-related development of endometriosis.

Authors:  Kaylon L Bruner-Tran; Grant R Yeaman; Marta A Crispens; Toshio M Igarashi; Kevin G Osteen
Journal:  Fertil Steril       Date:  2008-04-18       Impact factor: 7.329

3.  Meta-analysis of the association of AhR Arg554Lys, AhRR Pro185Ala, and ARNT Val189Val polymorphisms and endometriosis risk in Asians.

Authors:  Neng-neng Zheng; Ya-ping Bi; Ying Zheng; Ruo-heng Zheng
Journal:  J Assist Reprod Genet       Date:  2015-06-23       Impact factor: 3.412

4.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits human ovarian cancer cell proliferation.

Authors:  Yan Li; Kai Wang; Yi-Zhou Jiang; Xin-Wen Chang; Cai-Feng Dai; Jing Zheng
Journal:  Cell Oncol (Dordr)       Date:  2014-11-18       Impact factor: 6.730

5.  Is cytochrome P450 3A4 regulated by menstrual cycle hormones in control endometrium and endometriosis?

Authors:  Carla A Piccinato; Rosa M Neme; Natália Torres; Renata Silvério; Vanessa Bitencourt Pazzini; Júlio C Rosa E Silva; Rui A Ferriani
Journal:  Mol Cell Biochem       Date:  2016-12-19       Impact factor: 3.396

6.  The Role of Endocrine Disruptors in the Epigenetics of Reproductive Disease and Dysfunction: Potential Relevance to Humans.

Authors:  Kaylon L Bruner-Tran; David Resuehr; Tianbing Ding; John A Lucas; Kevin G Osteen
Journal:  Curr Obstet Gynecol Rep       Date:  2012-09-01

7.  ERβ- and prostaglandin E2-regulated pathways integrate cell proliferation via Ras-like and estrogen-regulated growth inhibitor in endometriosis.

Authors:  D Monsivais; M T Dyson; P Yin; J S Coon; A Navarro; G Feng; S S Malpani; M Ono; C M Ercan; J J Wei; M E Pavone; E Su; S E Bulun
Journal:  Mol Endocrinol       Date:  2014-07-03

8.  Estradiol and a selective estrogen receptor modulator affect steroid hormone receptor messenger RNA levels and turnover in explant cultures of sheep endometrium.

Authors:  Yuhua Z Farnell; Nancy H Ing
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002 Nov-Dec       Impact factor: 2.416

Review 9.  The role of the aryl hydrocarbon receptor in the female reproductive system.

Authors:  Isabel Hernández-Ochoa; Bethany N Karman; Jodi A Flaws
Journal:  Biochem Pharmacol       Date:  2008-10-14       Impact factor: 5.858

Review 10.  Exposure to the environmental endocrine disruptor TCDD and human reproductive dysfunction: Translating lessons from murine models.

Authors:  Kaylon L Bruner-Tran; Juan Gnecco; Tianbing Ding; Dana R Glore; Virginia Pensabene; Kevin G Osteen
Journal:  Reprod Toxicol       Date:  2016-07-14       Impact factor: 3.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.